Liver Cancer Therapeutics Market to Hit USD 15.69 Billion by 2032, growing at a CAGR of 19. ...
Liver Cancer Therapeutics Market Growth is Driven by Advancements in Precision Medicine, Immunotherapy and Growing Global Incidence.Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics ...
pharmaphorum20 天
Merck gets FDA okay for Keytruda as liver cancer therapy
The FDA approval is based on the results of the open-label KEYNOTE-224 trial, which enrolled 104 patients who had relapsed after or were refractory to Bayer’s Nexavar (sorafenib), the first-line ...
Drug Store News27 天
FDA accepts Alvotech, Teva's BLAs for Simponi biosimilars
Simponi and Simponi Aria (golimumab) are prescribed to treat a variety of inflammatory conditions. Southeastern Grocer's president and CEO and C&S Wholesale Grocers have acquired Southeastern ...